Disruption of kv1.3 channel forward vesicular trafficking by hypoxia in human T lymphocytes

Ameet A Chimote1, Zerrin Kuras, Laura Conforti

  • 1Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA.

Insights

Hypoxia in tumors reduces T cell function by decreasing Kv1.3 channels. This study reveals hypoxia disrupts Kv1.3 trafficking from the Golgi, impairing T cell immunosurveillance.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Hypoxia in solid tumors impairs T cell immunosurveillance by down-regulating Kv1.3 channels.
  • The precise mechanisms behind Kv1.3 channel down-regulation in T cells under hypoxic conditions remain unclear.

Purpose of the Study:

  • To investigate the role of membrane trafficking in hypoxia-induced down-regulation of Kv1.3 channels in T lymphocytes.
  • To elucidate the molecular mechanisms by which chronic hypoxia affects Kv1.3 surface expression and function.

Main Methods:

  • Utilized Jurkat T cells subjected to chronic hypoxia.
  • Assessed Kv1.3 surface expression and current density using electrophysiology and confocal microscopy.
  • Investigated the involvement of protein synthesis, degradation, endocytosis, and clathrin-coated vesicle trafficking.
  • Examined the expression and function of adaptor protein-1 (AP1) in the trans-Golgi network.

Main Results:

  • Chronic hypoxia significantly decreased Kv1.3 surface expression and current density in T cells.
  • Blocking clathrin-coated vesicle formation and forward trafficking prevented Kv1.3 down-regulation.
  • Hypoxia led to increased retention of Kv1.3 in the trans-Golgi and down-regulated AP1 expression.
  • Down-regulation of AP1 exacerbated Kv1.3 retention and reduced Kv1.3 currents.

Conclusions:

  • Hypoxia disrupts the AP1/clathrin-mediated forward trafficking of Kv1.3 channels from the trans-Golgi to the plasma membrane.
  • This trafficking disruption contributes to decreased Kv1.3 surface expression in T lymphocytes, potentially impairing T cell function and immunosurveillance in the tumor microenvironment.